Jiang Liu
Guangdong Medical College(CN)Key Laboratory of Guangdong Province(CN)Agricultural Product Processing Research Institute(CN)Guangdong Ocean University(CN)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Lung Cancer Treatments and Mutations, Statistical Methods in Clinical Trials, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia(2018)320 cited
- → Scientific white paper on concentration-QTc modeling(2017)250 cited
- → FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia(2018)245 cited
- → Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2(2021)231 cited
- → FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia(2018)191 cited
- → FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1(2020)179 cited